BIOCRINE

Diabetes is a complex syndrome of disordered metabolism. At Biocrine, the research goal is to understand what happens in the pancreatic gland; the role and interplay of hormones, receptors, and other molecules. We believe that every molecular event is of importance in the development of this complex disease. It is only by looking at all phenomena in relation to each other, that a clear picture of what leads to diabetes and how to fight it will emerge... Biocrine's goal is to commercialize new concepts of treatment and enable continuous delivery of novel drugs both for diabetes itself and for the complications that this disease induces.

Also known as: Biocrine AB

Primary location: Solna Sweden